Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
- Submitting institution
-
University of Southampton
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 66748404
- Type
- D - Journal article
- DOI
-
10.1016/S2213-2600(20)30397-0
- Title of journal
- The Lancet Respiratory Medicine
- Article number
- -
- First page
- 57
- Volume
- 9
- Issue
- 1
- ISSN
- 2213-2600
- Open access status
- Compliant
- Month of publication
- September
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
24
- Research group(s)
-
B - Healthy Ageing and Multimorbidity
- Citation count
- -
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a. The author made a substantial contribution to carrying out the study
and
b. The author helped draft the output; and critique the output for important intellectual content
- Non-English
- No
- English abstract
- -